University Emergency County Hospital of Cluj, Clinicilor 3-5, 400006 Cluj-Napoca, Romania.
Crit Care. 2010;14(6):R203. doi: 10.1186/cc9324. Epub 2010 Nov 9.
The immune responses in patients with novel A(H1N1) virus infection (nvA(H1N1)) are incompletely characterized. We investigated the profile of Th1 and Th17 mediators and interferon-inducible protein-10 (IP-10) in groups with severe and mild nvA(H1N1) disease and correlated them with clinical aspects.
Thirty-two patients hospitalized with confirmed nvA(H1N1) infection were enrolled in the study: 21 patients with nvA(H1N1)-acute respiratory distress syndrome (ARDS) and 11 patients with mild disease. One group of 20 patients with bacterial sepsis-ARDS and another group of 15 healthy volunteers were added to compare their cytokine levels with pandemic influenza groups. In the nvA(H1N1)-ARDS group, the serum cytokine samples were obtained on admission and 3 days later. The clinical aspects were recorded prospectively.
In the nvA(H1N1)-ARDS group, obesity and lymphocytopenia were more common and IP-10, interleukin (IL)-12, IL-15, tumor necrosis factor (TNF)α, IL-6, IL-8 and IL-9 were significantly increased versus control. When comparing mild with severe nvA(H1N1) groups, IL-6, IL-8, IL-15 and TNFα were significantly higher in the severe group. In nonsurvivors versus survivors, IL-6 and IL-15 were increased on admission and remained higher 3 days later. A positive correlation of IL-6, IL-8 and IL-15 levels with C-reactive protein and with > 5-day interval between symptom onset and admission, and a negative correlation with the PaO(2):FiO(2) ratio, were found in nvA(H1N1) groups. In obese patients with influenza disease, a significant increased level of IL-8 was found. When comparing viral ARDS with bacterial ARDS, the level of IL-8, IL-17 and TNFα was significantly higher in bacterial ARDS and IL-12 was increased only in viral ARDS.
In our critically ill patients with novel influenza A(H1N1) virus infection, the hallmarks of the severity of disease were IL-6, IL-15, IL-8 and TNFα. These cytokines, except TNFα, had a positive correlation with the admission delay and C-reactive protein, and a negative correlation with the PaO(2):FiO(2) ratio. Obese patients with nvA(H1N1) disease have a significant level of IL-8. There are significant differences in the level of cytokines when comparing viral ARDS with bacterial ARDS.
新型 A(H1N1) 病毒感染患者的免疫应答尚不完全清楚。我们研究了重症和轻症新型 A(H1N1) 疾病患者的 Th1 和 Th17 介质以及干扰素诱导蛋白-10(IP-10)的特征,并将其与临床特征相关联。
32 名确诊为新型 A(H1N1) 感染的住院患者纳入本研究:21 名新型 A(H1N1)合并急性呼吸窘迫综合征(ARDS)患者和 11 名轻症患者。另外还纳入了 20 名细菌性败血症合并 ARDS 患者和 15 名健康志愿者作为对照,比较各组细胞因子水平。在新型 A(H1N1)合并 ARDS 组中,入院时和入院后 3 天采集血清细胞因子样本。前瞻性记录临床特征。
在新型 A(H1N1)合并 ARDS 组中,肥胖和淋巴细胞减少更为常见,IP-10、白细胞介素(IL)-12、IL-15、肿瘤坏死因子(TNF)α、IL-6、IL-8 和 IL-9 水平明显升高。与轻症患者相比,重症患者的 IL-6、IL-8、IL-15 和 TNFα 水平显著升高。与存活者相比,死亡患者的 IL-6 和 IL-15 在入院时升高,且 3 天后仍升高。新型 A(H1N1)患者中,IL-6、IL-8 和 IL-15 水平与 C 反应蛋白呈正相关,与症状发作至入院时间间隔>5 天呈负相关,与 PaO(2):FiO(2) 比值呈负相关。在患流感的肥胖患者中,IL-8 水平明显升高。与病毒性 ARDS 相比,细菌性 ARDS 患者的 IL-8、IL-17 和 TNFα 水平显著升高,而只有病毒性 ARDS 患者的 IL-12 水平升高。
在患有新型 A(H1N1)病毒感染的危重症患者中,疾病严重程度的标志是 IL-6、IL-15、IL-8 和 TNFα。这些细胞因子(除 TNFα 外)与入院延迟和 C 反应蛋白呈正相关,与 PaO(2):FiO(2) 比值呈负相关。患新型 A(H1N1)病的肥胖患者的 IL-8 水平明显升高。病毒性 ARDS 与细菌性 ARDS 患者的细胞因子水平存在显著差异。